2mg Vial

Pharmaceutical Grade

Powder Form (requires mixture with bacteriostatic water for proper injection use)


  • Tesamorelin is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone (GHRH) indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Tesamorelin is also a growth hormone releasing hormone (GHRH) analog that has been shown to increase growth hormone and IGF-1 levels. Tesamorelin is currently the most effective GH releasing hormone on the market. It is an injectable peptide that generates greater natural production of HGH (Human Growth Hormone). It binds and stimulates human GHRH receptors with similar potency as our own natural GHRH.  

    More benefits of Tesamorelin include:

    •  Reduced triglycerides
    •  Reduced Visceral Adipose Tissue (VAT)
    •  Reduced Carotid Intima Media Size (cIMT)
    •  Improved cognition in adults over the age of 60


    Dosage: 2mg- 3mg/daily subcutaneously